← Eichor
Condition: Localized Prostate Adenocarcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Localized Prostate Adenocarcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06995053Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Local
NA · 1 location(s) · University of Zurich · NCT07042256Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05616650Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer
Phase 1/Phase 2 · 1 location(s) · The Methodist Hospital Research Institute · NCT07182279Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the
NA · 1 location(s) · Shanghai Changzheng Hospital · NCT06238713PSMA PET for Surveillance After Focal Therapy
NA · 1 location(s) · University of Chicago · NCT07115914ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0
Phase N/A · 1 location(s) · University of Milano Bicocca · NCT07407608Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer
Phase N/A · 3 location(s) · University of Zurich · NCT06834152Personalization of External Beam Radiation Therapy in Localised Tumours
Phase N/A · 1 location(s) · European Institute of Oncology · NCT07047495Two-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate Cancer
NA · 1 location(s) · UMC Utrecht · NCT06518226Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
NA · 5 location(s) · Mayo Clinic · NCT06325046High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04945642REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)
Phase 2 · 1 location(s) · National Cancer Institute, Naples · NCT07302451A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-r
Phase 2 · 2 location(s) · University of Chicago · NCT05726292Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in
NA · 2 location(s) · Centre Georges Francois Leclerc · NCT03417336Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07468903Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Pr
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06067269A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Phase 2 · 7 location(s) · Candel Therapeutics, Inc. · NCT07332000Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Ca
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07276438Two-fraction HDR Monotherapy for Localized Prostate Cancer
NA · 1 location(s) · University of California, San Francisco · NCT05665738Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
Phase 2 · 3 location(s) · Hackensack Meridian Health · NCT06798558Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
Phase 2 · 2 location(s) · David Oh · NCT03821246Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
Phase 1 · 1 location(s) · AdventHealth · NCT06631521Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness
NA · 1 location(s) · University Health Network, Toronto · NCT07339943Adaptive Stereotactic Radiotherapy for Localized Prostate Cancer
NA · 1 location(s) · Clinique Sainte Clotilde · NCT07344844Prostatic Size Reduction Following of Leuprorelin Acetate
Phase N/A · 1 location(s) · Consorci Sanitari de Terrassa · NCT06184464PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostat
Phase 2/Phase 3 · 1 location(s) · Affidea Nu-med Center of Oncological DIagnostics and Therapy · NCT07426055Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
NA · 1 location(s) · Case Comprehensive Cancer Center · NCT05610852Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · 133 location(s) · SWOG Cancer Research Network · NCT05806515Prospective Prostate Cancer and Patient-reported Outcomes Registry
Phase N/A · 4 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT04694924
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.